Clinical Trials Logo

Quality Improvement clinical trials

View clinical trials related to Quality Improvement.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05794490 Active, not recruiting - Resilience Clinical Trials

Learning From Excellence in a Hospital Unit

Start date: November 14, 2022
Phase:
Study type: Observational

This study is based on the implementation of the method named "Learning-from-excellence", see methodology www.learningfromexcellence.com. The project is a longitudinal cohort study based on data from both qualitative and quantitative data, presented in two different research articles, one qualitative and one quantitative, using : - an electronic questionnaire on "work-engagement, team collaboration and patient safety climate" before and after implementing Learning from Excellence. - focus group interviews to explore experiences with the method of Learning from excellence from the view of healthcare professionals.

NCT ID: NCT03724695 Active, not recruiting - Heart Failure Clinical Trials

Advanced Heart Care at Home

AHCAH
Start date: November 13, 2018
Phase: N/A
Study type: Interventional

End-of-life (EOL) care for heart failure (HF) patients includes high healthcare utilization and costs, in part due to the lack of integration of optimal HF management and home-based palliative care. In a pilot quality improvement project of clinician "nudges" to enroll seriously ill HF patients in a home-based, integrated HF and palliative care platform, the investigators demonstrated decreased healthcare utilization and costs and increased hospice utilization among seriously ill HF patients. The investigators propose a pragmatic randomized trial for clinicians of seriously ill HF patients admitted to three University of Pennsylvania Health System Hospitals, randomly assigning an opt-in approach (usual care) versus a "nudge" or opt-out approach of a visit from an Advanced Heart Care at Home (AHCAH) liaison to clinicians of eligible patients to discuss and enroll in the AHCAH program, to rigorously and scientifically evaluate clinical, utilization, and cost outcomes among high-risk HF patients at the EOL, and to promote physician uptake of best practices.